Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.
Sloand EM, Olnes MJ, Shenoy A, Weinstein B, Boss C, Loeliger K, Wu CO, More K, Barrett AJ, Scheinberg P, Young NS. Sloand EM, et al. Among authors: olnes mj. J Clin Oncol. 2010 Dec 10;28(35):5166-73. doi: 10.1200/JCO.2010.29.7010. Epub 2010 Nov 1. J Clin Oncol. 2010. PMID: 21041705 Free PMC article. Clinical Trial.
Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE. Olnes MJ, et al. N Engl J Med. 2012 Jul 5;367(1):11-9. doi: 10.1056/NEJMoa1200931. N Engl J Med. 2012. PMID: 22762314 Free PMC article. Clinical Trial.
Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab.
Lai C, Ranpura V, Wu C, Olnes MJ, Parikh AR, Shenoy A, Thompson J, Weinstein B, Scheinberg P, Barrett AJ, Desmond R, Young NS, Hourigan CS. Lai C, et al. Among authors: olnes mj. Blood Adv. 2019 Apr 9;3(7):980-983. doi: 10.1182/bloodadvances.2018030411. Blood Adv. 2019. PMID: 30936058 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 32439728
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome.
Vicente A, Patel BA, Gutierrez-Rodrigues F, Groarke E, Giudice V, Lotter J, Feng X, Kajigaya S, Weinstein B, Barranta E, Olnes MJ, Parikh AR, Albitar M, Wu CO, Shalhoub R, Calvo KR, Townsley DM, Scheinberg P, Dunbar CE, Young NS, Winkler T. Vicente A, et al. Among authors: olnes mj. Haematologica. 2020 Dec 1;105(12):2785-2794. doi: 10.3324/haematol.2020.249995. Haematologica. 2020. PMID: 33256377 Free PMC article.
Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.
Ito S, Bollard CM, Carlsten M, Melenhorst JJ, Biancotto A, Wang E, Chen J, Kotliarov Y, Cheung F, Xie Z, Marincola F, Tanimoto K, Battiwalla M, Olnes MJ, Perl S, Schum P, Hughes TE, Keyvanfar K, Hensel N, Muranski P, Young NS, Barrett AJ. Ito S, et al. Among authors: olnes mj. Mol Ther. 2014 Jul;22(7):1388-1395. doi: 10.1038/mt.2014.50. Epub 2014 Apr 1. Mol Ther. 2014. PMID: 24686272 Free PMC article.
42 results